SES Logo

SYSTEMIC ENZYME SUPPORT.org

 

Sports Medicine

There are a number of ways that athletes benefit from regular use of Wobenzym® N. The first would be the ability of Wobenzym® N to improve athletic performance by decreasing the inflammatory consequences of that intense physical activity brings about. While the demands of athletic performance tend to improve physical health and cumulatively improve further athletic performance, over training and excessive strain leads to tissue damage with the undesirable consequence of inflammation.
Most of us have experienced the increased achiness that is common after exercise – sometimes it shows up a couple of days after the workout. This represents a degree of inflammation that the body has to recover from.
Think of this a micro-trauma. There is not a bruise, sprain or broken bone, but there is inflammation. Now, as far as the body is concerned, inflammation is inflammation – so the body’s resources are being used to react to that inflammation. Specifically; cytokines – those inflammation promoting molecules we have talked about – are increased after intense physical exercise.
As we discussed earlier, Wobenzym® N decreases pro-inflammatory cytokines. As such, it shortens the duration of post exercise inflammation.
The excellent results have been observed in athletes using Wobenzym® N can be explained by its ability to interfere with the inflammation caused by athletic micro-trauma. In this fashion, it improves recovery time.
                                                          From FREQUENTLY ASKED QUESTIONS, with answers by Joseph J Collins, RN, ND
                                                          Read the special section:
TRAUMA, SURGERY, SPORTS MEDICINE & WOBENZYM®

 What the literature says about Systemic Enzyme Support and:

Sports Medicine

Physical activity and immune system. Systemic enzyme therapy in prevention and treatment.  

Nouza K. Physical activity and immune system. Systemic enzyme therapy in prevention and treatment. Medicina Sportiva Boh. Slov. 1997, Vol. 6., No. 2, pp. 41 - 45  

Summary

Besides serious infections, injuries. burns and irradiation, stress is also provoked by a strong physical tension, excessive training and heavy competition rate - factors of professional sporting activity. An important consequence of stress is on affliction of the immune system, its factors and functions, leading secondarily to a decrease of antiinfectious resistance and antitumor surveillance.
While experimental as well as medical experience indicate that regular exercise and recreation sport affects immune system and its function favourably, overtraining, and excessive strain lead to its damage with undesirable consequences. A higher sensitivity to infections is the most prominent: several small-range epidemics have been announced. The paper summarizes main information about changes in the immune system in professionals accomplishing demanding sports - marathon runners, karatists, skiers, cyclists and others. The immune cells (granulocytes, lymphocytes, monocytes, NK) react after an early temporal mobilization with a decline in numbers as well as in functional activities. Similarly, blood levels of immunoglobulins (notably IgA) tend (after a short-time increase) to fall down, often for prolonged time period; the same applies to factors of natural immunity. As underlying mechanisms of these effects there are stress-mediated disturbances of homeostasis, overproduction of some cytokines, adhesive molecules, and toxic radicals.
Among preventive and therapeutic procedures the attention is paid mainly to combination of proteolytic enzymes. Surprisingly excellent practical results may be satisfactorily explained by selective interferences of enzymes with the pathophysiologic mechanisms of inflammation and by their complex immunomodulatory (immunonormalizing) effects.
Key words: sport, stress, disturbance of immunity, systemic enzyme therapy Poster Reference Number 38.  

Prophylactic administration of Wobenzym to reduce consequences of sports injuries in karate fighters.  

Zuschlag J.-M. Prophylactic administration of Wobenzym to reduce consequences of sports injuries in karate fighters. MUCOS Pharma GmbH & Co, Dept. Clinical Research, Geretsried, Germany.  

In a double blind, placebo controlled, randomised clinical trial the efficacy and tolerance of WOBENZYM® adminstration was proved to reduce the consequences of sports injuries in top sportsmen.
20 karate fighters, aged between 13 and 21 years, who underwent a regular training, were included into the trial. 10 volunteers received in the Phase I Wobenzym tablets and in the Phase II placebo, whereas other 10 sportsmen received in the Phase I placebo and in the Phase II Wobenzym.
Main evaluation criteria were training absence and absence at work or at school.
Other criteria were duration of hematomas, edema, rest pain, pain on movement, pain on pressure, restricted motility and general inflammatory reactions.
Frequency as well as severity of symptoms were comparable in both groups.
However, their duration was statistically significantly shorter under Wobenzym treatment. Evaluation of main criteria was statistically significantly better in the enzyme group (training absence 2.2 days compared to 9.5 days in the placebo group, p = 2.87 x 10-6; absence at work or at school 0.2 days compared to 1.8 days, p = 0.024). Evaluation of all other criteria showed statistically significantly better result in the enzyme group as compared to the placebo group (p < 0.001).
One case of adverse events was reported in the enzyme group: a slight diarrhea which lasted for five days and did not require any changes of the therapy. There was a possible association with Wobenzym treatment.
In the study it has been proven that prophylactic administration of Wobenzym (3x5 tablets daily) in top sportsmen showing a higher risk of injury significantly reduces duration of injury symptoms and training and work absence as a consequence of such injuries.
Poster Reference Number 78.  

A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes.  

Kerkhoffs GM, Struijs PA, de Wit C, Rahlfs VW, Zwipp H, van Dijk CN. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes. Br J Sports Med. 2004 Aug;38(4):431-5.  

OBJECTIVE: To compare the effectiveness and safety of the triple combinationPhlogenzym (rutoside, bromelain, and trypsin) with double combinations, thesingle substances, and placebo. DESIGN: Multinational, multicentre, double blind,randomised, parallel group design with eight groups structured according to afactorial design. SETTING: Orthopaedic surgery and emergency departments in 27European hospitals. PARTICIPANTS: A total of 721 patients aged 16-53 yearspresenting with acute unilateral sprain of the lateral ankle joint. PRIMARYEFFICACY CRITERIA: (a) Pain on walking one or two steps, as defined by thepatient on a visual analogue scale. (b) The range of motion, as measured by theinvestigator and expressed as a sum of flexion and extension. (c) The volume ofthe injured ankle measured with a volometer. RESULTS: At the primary end point atseven days, the greatest reduction in pain was in the bromelain/trypsin group(73.7%). The Phlogenzym group showed a median reduction of 60.3%, and the placebogroup showed a median reduction of 73.3%. The largest increase in range of motion(median) was in the placebo group (60% change from baseline). The Phlogenzymgroup showed a median increase of 42.9%. The biggest decrease in swelling was in the trypsin group (3.9% change from baseline). The Phlogenzym group showed a-2.30% change from baseline and the placebo group a -2.90% change. In thesubgroup analysis of patients who did not use a Caligamed brace, Phlogenzym wassuperior to placebo for the summarising directional test of the primary efficacy criteria (MW = 0.621; LB-CI 0.496; p = 0.029; one sided Wei-Lachin procedure).The vast majority of doctors and patients rated the tolerability of alltreatments tested as very good or at least good.
CONCLUSIONS: Phlogenzym was not found to be superior to the three two-drug combinations, the three singlesubstances, or placebo for treatment of patients with acute unilateral sprain of the lateral ankle joint. The small subgroup of patients treated without thesupport of a Caligamed brace showed evidence of superiority of Phlogenzym overplacebo. Further research is warranted to study this effect of Phlogenzym inpatients treated without ankle support.
External Link:
PMID: 15273178
Poster Reference Number 79.  

Physical activity and immune system. Systemic enzyme therapy in prevention and treatment.  

Nouza K. Physical activity and immune system. Systemic enzyme therapy in prevention and treatment. Medicina Sportiva Boh. Slov. 1997, Vol. 6., No. 2, pp. 41 - 45   

Summary
Besides serious infections, injuries. burns and irradiation, stress is also provoked by a strong physical tension, excessive training and heavy competition rate - factors of professional sporting activity. An important consequence of stress is on affliction of the immune system, its factors and functions, leading secondarily to a decrease of antiinfectious resistance and antitumor surveillance.
While experimental as well as medical experience indicate that regular exercise and recreation sport affects immune system and its function favourably, overtraining, and excessive strain lead to its damage with undesirable consequences. A higher sensitivity to infections is the most prominent: several small-range epidemics have been announced. The paper summarizes main information about changes in the immune system in professionals accomplishing demanding sports - marathon runners, karatists, skiers, cyclists and others. The immune cells (granulocytes, lymphocytes, monocytes, NK) react after an early temporal mobilization with a decline in numbers as well as in functional activities. Similarly, blood levels of immunoglobulins (notably IgA) tend (after a short-time increase) to fall down, often for prolonged time period; the same applies to factors of natural immunity. As underlying mechanisms of these effects there are stress-mediated disturbances of homeostasis, overproduction of some cytokines, adhesive molecules, and toxic radicals.
Among preventive and therapeutic procedures the attention is paid mainly to combination of proteolytic enzymes. Surprisingly excellent practical results may be satisfactorily explained by selective interferences of enzymes with the pathophysiologic mechanisms of inflammation and by their complex immunomodulatory (immunonormalizing) effects.
Key words: sport, stress, disturbance of immunity, systemic enzyme therapy Poster Reference Number 80.  

Use of systemic enzyme therapy in the treatment of hand injuries and their consequences.  

Naumenko L. Yu. Use of systemic enzyme therapy in the treatment of hand injuries and their consequences.Presented at the conference ”Current treatment aspects of wrist injuries and their consequences”, Dnepropetrovsk 1998  

Wobenzym was administered to the 3 groups of patients (total 52) with various hand traumas:
 
Consequences of traumas which needed reconstructive surgery – 15 patients
 
Acute hand traumas – 27 patients
 
Hand diseases – 10 patients
Wobenzym was administered according to the standard scheme – 7-10 dragees 3 times a day.
Patients in the 1st group were treated preoperatively (7 days before surgery) and subsequently over 12 days postoperatively. Preoperative treatment showed a positive influence on edema and pain syndrome during a postoperative period.
In Wobenzym-treated patients, edema decreased during 7 preoperative days to 27% (in comparison to 53% in the control group). During early postoperative period edema increased to approx. 60% of the initial condition (compared to the 100% in the control group). Within 12 days after surgery, edema decreased to 7% of the initial condition (19% in the control group). A fast regression of pain syndrome in the Wobenzym-treated patients enabled a discontinuation of analgesic drugs from 2-3 days after surgery.
Patients in the 2nd group were treated with Wobenzym for 1 month (longer treatment because of trauma severity). Characteristics of edema and pain syndrome development were similar to that of the 1st group.
Patients in the 3rd group were treated with Wobenzym for 2-3 months. A salutary effect of enzyme therapy in combination with anti-edematous and analgesic drugs occurred during II-III weeks of treatment. Wobenzym treatment led to a significant decrease of CRP and sedimentation.
Wobenzym was well tolerated by most of the patients. Side-effects occurred in 2 patients and disappeared after dose lowering.
Poster Reference Number 81.